Zoekresultaten - 132 results
The European response to the WHO call cervical cancer as a public health problem
Issue 2 (2021) Keywords: cervical cancer screening COVID-19 elimination of cervical cancer Europe HPV vaccination WHO Abstract: The age‐standardised incidence of cervical cancer in Europe varies widely ...
HPV DNA genotyping, HPV E6*I mRNA detection, and p16INK4a/Ki-67 staining in Belgian head and neck cancer patient specimens, collected within the HPV-AHEAD study
Madhavan Radhakrishna; Radhakrishna, Madhavan; Bogers, Johannes; Pawlita, Michael; Tommasino, Massimo; M. Arbyn; HPV-AHEAD study group Source: Cancer Epidemioly, Volume 72 (2021) Keywords: Adult Aged Aged, ...
Cervical cancer screening using HPV tests on self-samples: attitudes and preferences of women participating in the VALHUDES study
Severien Van Keer; Alex Vorsters; M. Arbyn Source: Archives of Public Health, Volume 79, Issue 1 (2021) Keywords: ATTITUDES cervical cancer HPV human papillomavirus Preferences SCREENING self-sampling urine ...
Tackling cervical cancer in Europe amidst the COVID-19 pandemic.
estimates for 2018, approximately 33 000 cases of cervical cancer occurred and 15 000 people died from the disease in Europe (see map in appendix). Human papillomavirus (HPV) vaccine coverage is relatively ...
Might Oral Human Papillomavirus (HPV) Infection in Healthy Individuals Explain Differences in HPV-Attributable Fractions in Oropharyngeal Cancer? A Systematic Review and Meta-analysis.
BACKGROUND: Differences in oral human papillomavirus (HPV) prevalence and contrasts in HPV-attributable fractions (AF s) in oropharyngeal cancer (OPC) have not been evaluated in depth. METHODS: A systematic ...
Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology.
Publication Type: Peer reviewed scientific article Authors: Peeters, Eliana; Wentzensen, Nicolas; Bergeron, Christine; M. Arbyn Source: Cancer Cytopathol, Volume 127, Issue 3 (2019) Keywords: Atypical Squamous Cells of the Cervix Cyclin-Dependent Kinase I ...
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017)- Part 2 on Triage, Treatment and Follow-up.
neoplasia (CIN) cervical precancerous condition HPV Abstract: EN AIMS Annual opportunistic screening for cervical carcinoma has been done in Germany since 1971. The creation of this S3 guideline meets an ...
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017)- Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia.
neoplasia (CIN) cervical precancerous condition HPV Abstract: AIMS Annual opportunistic screening for cervical carcinoma has been carried out in Germany since 1971. The creation of this S3 guideline meets an ...
Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
Factors Sweden Uterine Cervical Dysplasia Uterine Cervical Neoplasms Abstract: BACKGROUND The causal relation between high-risk human papillomavirus (HPV) and cervical cancer and its precursor lesions has ...
Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia
cancer Cervical cancer prevention EVALUATION Health economics Modelling Simulation Abstract: OBJECTIVE Australia’s HPV vaccination and HPV-based cervical screening programs are changing the landscape in ...